US-based NIRF Imaging and Exelis have joined forces to develop and market a near-infrared fluorescence imaging technology for point-of-care diagnostic applications.
Under the terms of agreement, Exelis will provide NIRF Imaging with its proprietary Pinnacle Gen III image intensifier (I2) tubes, which have historically been used primarily in military-grade night-vision goggles, for use as a key component in NIRF Imaging’s proprietary medical imaging technology.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to the company, the ability to provide a ‘ready-now’ technology such as Pinnacle was a key factor in selecting Exelis as a partner.
The signing of this strategic alliance is the result of a long-term relationship between the two companies.
NIRF Imaging will use Exelis’ state-of-the-art image intensification technology as a key component in a proprietary medical imaging technology-based on near infrared fluorescence (NIRF) and micro-doses of nonradioactive dye in order to produce a new tool for imaging patients’ lymphatic system.
NIRF Imaging CEO Christopher Fashek said: "Not only is their image intensifier a key component of our technology, but also Exelis’s world-class reputation in innovation, design, quality and manufacturing will have a significant impact in helping us achieve our strategic initiatives."
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAlso, with NIRF technology development completed and validated in multiple clinical studies, NIRF Imaging and Exelis will finalise both the commercial design and manufacturing process for NIRF Imaging’s initial product, the NIRF-LI system.
The NIRF-LI system is expected to provide physicians and surgeons with a dynamic, non-invasive, point-of-care imaging system available for imaging the body’s lymphatic system, without the risks associated with radioactive imaging agents.
Exelis Night Vision business vice-president and general manager Dave Smith said: "NIRF Imaging represents an ideal expansion partner. Our image intensifier is a differentiating component in NIRF Technology and we look forward to deploying our commercialisation design, manufacturing resources and expertise to help NIRF Imaging address significant unmet needs within the global medical imaging market."
